Fishing for myelodysplastic syndromes finds uncaptured cases by state cancer registries: Need for more resources
|
Mar 2014
|
Cancer
|
myelodysplastic syndromes (MDS)
|
A call for action: Increasing enrollment of untreated patients with higher-risk myelodysplastic syndromes in first-line clinical trials.
|
Jul 2017
|
Cancer
|
myelodysplastic syndromes (MDS)
|
Disparity in perceptions of disease characteristics, treatment effectiveness, and factors influencing treatment adherence between physicians and patients with myelodysplastic syndromes
|
Feb 2014
|
Cancer
|
myelodysplastic syndromes (MDS)
|
Lenalidomide performance in the real world: Patterns of use and effectiveness in a Medicare population with myelodysplastic syndromes.
|
Aug 2013
|
Cancer
|
myelodysplastic syndromes (MDS)
|
Counselling and adverse event management for patients with myelodysplastic syndromes undergoing azacitidine therapy: a practice standard for Canadian nurses
|
Oct 2012
|
Can Oncol Nurs J
|
myelodysplastic syndromes (MDS)
|
Therapy-related myelodysplastic syndromes in the genomics era
|
Jun 2023
|
Bulletin du Cancer
|
myelodysplastic syndromes (MDS)
|
Paroxysmal nocturnal haemoglobinuria (PNH): novel therapies for an ancient disease
|
Nov 2020
|
British Journal of Haematology
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
The evolving role of next generation sequencing in myelodysplastic syndromes
|
Oct 2019
|
British Journal of Haematology
|
myelodysplastic syndromes (MDS)
|
PNH Phenotypes and Their Genesis
|
Jun 2020
|
British Journal of Haematology
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
In Search for a Haemoglobin Threshold in Myelodysplastic Syndromes
|
Jun 2020
|
British Journal of Haematology
|
myelodysplastic syndromes (MDS)
|